secwatch.observer — SEC 8-K summary
======================================

Issuer:     iRhythm Holdings, Inc. (IRTC)
CIK:        0001388658
Form:       8-K
Filed at:   2022-08-05T23:59:59+00:00
Accession:  0001388658-22-000126
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRhythm Q2 revenue $102.1M (+26% YoY), raises FY22 guidance to $415-420M, loss widens
--------------------------------------------------------------------------------

- Revenue $102.1M (+25.6% YoY); gross margin 68.8% (up 0.8pp).
- Net loss $23.9M ($0.80 loss per share) vs $17.4M loss in Q2 2021.
- FY22 revenue guidance raised to $415-420M (29-30% growth); adj. EBITDA loss guidance $(12.5)-$(17.5)M.
- Cash $204.5M; record new account openings (+22% QoQ) and sequential revenue volume growth of 10%.
- FDA 510(k) cleared Zio Watch (Verily partnership); CMS proposed reimbursement for Zio XT CPT codes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388658/000138865822000126/0001388658-22-000126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388658/000138865822000126/irtc-20220804.htm
  HTML page:      https://secwatch.observer/filing/0001388658-22-000126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer